Date :
Place : United Kingdom, London
Website :http://go.evvnt.com/2688752-0?pid=80
Contact Person:Jessica Durston
Description:
Explore Novel Payloads, Maximize Clinical Efficacy and Accelerate Manufacturing Timelines to Bring More ADCs to a Wider Patient Population Faster. Time: 8:00 am to 5:00 pm. Prices: GBP 2319.00 - GBP 6315.00Deadline for abstracts/proposals : 3rd March 2025
Organized By :
Keynote Speakers :
Conference Highlights :Home | 15th World ADC London 2025 | 3-6 March, 2025
Meet leading biopharma and academics in London at Europe’s definitive Antibody-Drug Conjugate event covering end-to-end drug development
⭐ Your Flagship ADC Event in Europe
Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has seen a surge in multi-billion-dollar acquisitions, commercialisation deals, and licensing agreements. These developments have enabledthe ADC community to make strides in bringing these therapies to earlier-line treatments and expand their use to wider patient populations.
Returning for its 15th anniversary year,World ADC Londonis the leading European conference uniting over 1000 ADC enthusiasts tomaximise the therapeutic index of ADCs. Whether you are brand new to the field or have over a decade of experience, work in discovery or manufacturing, hold a strategic position or work day-to-day in the lab, this meeting offers something for you!
Check the event website for more details.